<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>tumor invasion &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/tumor-invasion/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 08 Oct 2026 20:59:02 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>tumor invasion &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Liver Cancer&#8217;s Hidden Brake: How A20 Marks a Key Tumor Protein for Destruction</title>
		<link>https://bioengineer.org/liver-cancers-hidden-brake-how-a20-marks-a-key-tumor-protein-for-destruction/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Thu, 08 Oct 2026 20:59:02 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[A20]]></category>
		<category><![CDATA[biomarkers]]></category>
		<category><![CDATA[Cell proliferation]]></category>
		<category><![CDATA[Hepatocellular Carcinoma]]></category>
		<category><![CDATA[liver cancer]]></category>
		<category><![CDATA[Medical Oncology]]></category>
		<category><![CDATA[osteopontin]]></category>
		<category><![CDATA[prognosis]]></category>
		<category><![CDATA[TNFAIP3]]></category>
		<category><![CDATA[tumor invasion]]></category>
		<category><![CDATA[ubiquitin-proteasome system]]></category>
		<category><![CDATA[Ubiquitination]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=408286</guid>

					<description><![CDATA[New research reveals that the ubiquitin-editing enzyme A20 promotes the degradation of the pro-tumor protein osteopontin in hepatocellular carcinoma, offering both a mechanistic insight and a potential prognostic marker pair for patients after tumor resection.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">408286</post-id>	</item>
	</channel>
</rss>
